End of Distribution Compliance Period
Distribution compliance period under Regulation S has ended; REG S designation removed from securities.
Select text to share a quote on X · sign in to keep highlights & notes in your AOTI notes
AOTI, INC. (AIM: AOTI), a medical technology group focused on the durable healing of wounds and the prevention of amputations, announces that the 'distribution compliance period' (as set out under Regulation S of the US Securities Act of 1933, as amended (the 'Securities Act')) has now ended and the 'REG S' designation for the Company's securities will be removed.
The distribution compliance period (which lasted 12 months) was in place to restrict the resale of securities for the account of, or benefit of, certain US Persons (as defined under the Securities Act).
| AOTI, INC. Dr. Mike Griffiths, Chief Executive Officer Jayesh Pankhania, Chief Financial Officer | +44 (0)20 3727 1000 ir@aotinc.net |
| Peel Hunt LLP (Nominated Adviser and Broker) Dr. Christopher Golden, James Steel | +44 (0)20 7418 8900 |
| FTI Consulting (Financial PR & IR) Ben Atwell, Simon Conway, Natalie Garland-Collins, Alex Davis | +44 (0)20 3727 1000 AOTI@fticonsulting.com |
ABOUT AOTI, INC.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.